CLEVELAND, OHIO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the planet through a ...

MISSISSAUGA, Ontario, Sept. 20, 2024 (GLOBE NEWSWIRE) -- (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce ...

LAS VEGAS, Sept. 20, 2024 /PRNewswire/ -- Allegiant Travel Company (NASDAQ: ALGT) today reported preliminary passenger ...

Northrop Grumman Corporation (NYSE: NOC) announced today that its third quarter 2024 financial results will be posted on its investor relations website on Oct. 24, 2024. Prior to the market opening, ...

CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: QLGN) (the “Company”) today announced that on September 11, ...

Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral ...

Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing ...

Key Insights Institutions' substantial holdings in TPI Composites implies that they have significant influence over ...

CALGARY, Alberta, Sept. 20, 2024 (GLOBE NEWSWIRE) -- (“Canacol” or the “Corporation”) (TSX: CNE; OTCQX: CNNEF; BVC: CNEC) announces that it has revised its 2024 capital program, comments on 2024 ...

Key Insights Significant control over Largo by private equity firms implies that the general public has more power ...

Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared to placebo, consistent with improvements seen in ...

In-Memory Database Market In-Memory Database Market Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "In-Memory Database - ...